Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention

Background Limiting the contrast volume to creatinine clearance (V/CrCl) ratio is crucial for preventing contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI). However, the incidence of CI-AKI and the distribution of V/CrCl ratios may vary according to patient body habitus. Objective We aimed to identify the clinical factors predicting CI-AKI in patients with different body mass indexes (BMIs). Methods We evaluated 8782 consecutive patients undergoing PCI and who were registered in a large Japanese database. CI-AKI was defined as an absolute serum creatinine increase of 0.3 mg/dL or a relative increase of 50%. The effect of the V/CrCl ratio relative to CI-AKI incidence was evaluated within the low- (≤25 kg/m2) and high- (>25 kg/m2) BMI groups, with a V/CrCl ratio > 3 considered to be a risk factor for CI-AKI. Results A V/CrCl ratio > 3 was predictive of CI-AKI, regardless of BMI (low-BMI group: odds ratio [OR], 1.77 [1.42–2.21]; P < 0.001; high-BMI group: OR, 1.67 [1.22–2.29]; P = 0.001). The relationship between BMI and CI-AKI followed a reverse J-curve relationship, although baseline renal dysfunction (creatinine clearance <60 mL/min, 46.9% vs. 21.5%) and V/CrCl ratio > 3 (37.3% vs. 20.4%) were predominant in the low-BMI group. Indeed, low BMI was a significant predictor of a V/CrCl ratio > 3 (OR per unit decrease in BMI, 1.08 [1.05–1.10]; P < 0.001). Conclusions A V/CrCl ratio > 3 was strongly associated with the occurrence of CI-AKI. Importantly, we also identified a tendency for physicians to use higher V/CrCl ratios in lean patients. Thus, recognizing this trend may provide a therapeutic target for reducing the incidence of CI-AKI.

[1]  M. Liang,et al.  Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention , 2018, Angiology.

[2]  S. Yuasa,et al.  Characteristics and in-hospital outcomes in young patients presenting with acute coronary syndrome treated by percutaneous coronary intervention , 2018, Cardiovascular Intervention and Therapeutics.

[3]  S. Yuasa,et al.  Predictors of high cost after percutaneous coronary intervention: A review from Japanese multicenter registry overviewing the influence of procedural complications , 2017, American heart journal.

[4]  J. Spertus,et al.  Association of Variation in Contrast Volume With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention , 2017, JAMA cardiology.

[5]  K. Wieczorowska-Tobis,et al.  Assessment of renal function in geriatric palliative care patients – comparison of creatinine-based estimation equations , 2017, Clinical interventions in aging.

[6]  H. Miyata,et al.  Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[7]  T. Murohara,et al.  Impact of nutritional assessment and body mass index on cardiovascular outcomes in patients with stable coronary artery disease. , 2017, International journal of cardiology.

[8]  H. Miyata,et al.  Impact of Institutional and Operator Volume on Short-Term Outcomes of Percutaneous Coronary Intervention: A Report From the Japanese Nationwide Registry. , 2017, JACC. Cardiovascular interventions.

[9]  Sidney C. Smith,et al.  Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome. , 2016, American heart journal.

[10]  H. Miyata,et al.  Effect of Smoking Status on Clinical Outcome and Efficacy of Clopidogrel in Acute Coronary Syndrome. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[11]  H. Miyata,et al.  Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan. , 2016, Journal of the American College of Cardiology.

[12]  Y. Arbel,et al.  Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity , 2016, Journal of Nephrology.

[13]  H. Miyata,et al.  An international comparison of patients undergoing percutaneous coronary intervention: A collaborative study of the National Cardiovascular Data Registry (NCDR) and Japan Cardiovascular Database-Keio interhospital Cardiovascular Studies (JCD-KiCS). , 2015, American heart journal.

[14]  H. Miyata,et al.  Outcomes of Percutaneous Coronary Intervention Performed With or Without Preprocedural Dual Antiplatelet Therapy. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[15]  Lichuan Yang,et al.  Novel risk score of contrast‐induced nephropathy after percutaneous coronary intervention , 2015, Nephrology.

[16]  H. Miyata,et al.  Angiographic Lesion Complexity Score and In-Hospital Outcomes after Percutaneous Coronary Intervention , 2015, PloS one.

[17]  H. Miyata,et al.  Impact of Body Mass Index on In-Hospital Complications in Patients Undergoing Percutaneous Coronary Intervention in a Japanese Real-World Multicenter Registry , 2015, PloS one.

[18]  H. Miyata,et al.  Location of the culprit coronary lesion and its association with delay in door-to-balloon time (from a multicenter registry of primary percutaneous coronary intervention). , 2015, The American journal of cardiology.

[19]  H. Miyata,et al.  Gender Differences in In-Hospital Clinical Outcomes after Percutaneous Coronary Interventions: An Insight from a Japanese Multicenter Registry , 2015, PloS one.

[20]  Michael E. Matheny,et al.  Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Registry Cath‐PCI Registry , 2014, Journal of the American Heart Association.

[21]  E. Edelman,et al.  Intravascular Ultrasound Guidance to Minimize the use of Iodine Contrast in Percutaneous Coronary Intervention: The MOZART Randomized Controlled Trial , 2014 .

[22]  H. Gurm,et al.  The Association between Contrast Dose and Renal Complications Post PCI across the Continuum of Procedural Estimated Risk , 2014, PloS one.

[23]  H. Miyata,et al.  Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[24]  H. Miyata,et al.  Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome , 2013, PloS one.

[25]  T. Uejima,et al.  Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study. , 2013, Journal of cardiology.

[26]  A. Rosengren,et al.  Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. , 2013, European heart journal.

[27]  H. Gurm,et al.  The burgeoning epidemic of morbid obesity in patients undergoing percutaneous coronary intervention: insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. , 2012, Journal of the American College of Cardiology.

[28]  J. Wetzels,et al.  Epidemiology of contrast material-induced nephropathy in the era of hydration. , 2012, Radiology.

[29]  B. Afşar,et al.  Which anthropometric parameter is best related with urinary albumin excretion and creatinine clearance in type 2 diabetes: body mass index, waist circumference, waist-to-hip ratio, or conicity index? , 2011, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[30]  H. Gurm,et al.  Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. , 2011, Journal of the American College of Cardiology.

[31]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[32]  Hani Jneid,et al.  2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in , 2011, Journal of the American College of Cardiology.

[33]  J. Messenger,et al.  Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. , 2010, Journal of the American College of Cardiology.

[34]  P. Damman,et al.  Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes , 2009, Heart.

[35]  Sunil V. Rao,et al.  Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry , 2009, Circulation. Cardiovascular interventions.

[36]  R. R. Wolfe,et al.  The danger of weight loss in the elderly , 2008, The journal of nutrition, health & aging.

[37]  P. McCullough,et al.  Contrast-induced acute kidney injury. , 2018, Journal of the American College of Cardiology.

[38]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[39]  Sidney C. Smith,et al.  Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. , 2007, The American journal of cardiology.

[40]  F. Veglia,et al.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[41]  P. McCullough,et al.  Epidemiology of contrast-induced nephropathy. , 2003, Reviews in cardiovascular medicine.

[42]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[43]  N. Weissman,et al.  The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? , 2002, Journal of the American College of Cardiology.

[44]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .